Core Historical Income Statement

CLB Stock

USD 20.41 0.14 0.68%

Historical analysis of Core Laboratories income statement accounts such as Interest Expense of 10.1 M, Selling General Administrative of 34.6 M or Total Revenue of 619.3 M can show how well Core Laboratories NV performed in making a profits. Evaluating Core Laboratories income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Core Laboratories's future profits or losses.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Core Laboratories latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Core Laboratories is a good buy for the upcoming year.

Net Income Gross Profit

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Core Laboratories NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

About Core Income Statement Analysis

Core Laboratories Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Core Laboratories shareholders. The income statement also shows Core investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Core Laboratories Income Statement Chart

At present, Core Laboratories' Depreciation And Amortization is projected to decrease significantly based on the last few years of reporting. The current year's Total Revenue is expected to grow to about 619.3 M, whereas Interest Expense is forecasted to decline to about 10.1 M.

Selling General Administrative Total Revenue Gross Profit Other Operating Expenses

Total Revenue

Total revenue comprises all receipts Core Laboratories generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Core Laboratories NV minus its cost of goods sold. It is profit before Core Laboratories operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Core Laboratories. It is also known as Core Laboratories overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Most accounts from Core Laboratories' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Core Laboratories current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Core Laboratories NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

	2021	2022	2023	2024 (projected)
Gross Profit	83.8M	78.9M	94.0M	171.1M
Total Revenue	470.3M	489.7M	509.8M	619.3M

Gross Profit Total Revenue

Core Laboratories income statement Correlations

	Depreciation And Amortization	Interest Expense	Selling General Administrative	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Selling And Marketing Expenses	Minority Interest	Net Income From Continuing Ops	Non Operating Income Net Other	Tax Provision	Interest Income	Discontinued Operations	Net Interest Income	Extraordinary Items	Reconciled Depreciation	Non Recurring
Depreciation And Amortization		0.09	0.07	0.47	0.48	0.42	0.47	0.33	0.4	0.44	0.14	0.39	-0.12	0.32	0.54	-0.36	-0.43	0.21	0.34	0.31	-0.17	-0.63	0.24	-0.62	0.03	-0.06
Interest Expense	0.09		0.72	0.34	0.11	0.53	0.03	-0.03	-0.02	0.51	0.64	-0.08	-0.44	-0.05	-0.12	-0.85	0.2	-0.38	0.82	-0.52	0.25	0.37	-0.47	0.38	-0.26	-0.05
Selling General Administrative	0.07	0.72		0.68	0.5	0.81	0.43	0.47	0.46	0.79	0.89	0.42	-0.04	0.43	0.35	-0.82	0.45	0.13	0.86	-0.01	0.1	0.21	-0.02	0.2	0.09	0.15
Total Revenue	0.47	0.34	0.68		0.96	0.97	0.93	0.9	0.91	0.98	0.72	0.89	0.22	0.87	0.84	-0.61	0.04	0.66	0.65	0.4	0.18	-0.08	0.08	-0.11	0.41	0.13
Gross Profit	0.48	0.11	0.5	0.96		0.88	0.98	0.94	0.95	0.89	0.59	0.95	0.32	0.92	0.92	-0.39	0.0	0.79	0.44	0.57	0.18	-0.19	0.14	-0.23	0.51	0.14
Other Operating Expenses	0.42	0.53	0.81	0.97	0.88		0.82	0.8	0.81	1.0	0.82	0.78	0.13	0.78	0.72	-0.76	0.09	0.5	0.8	0.24	0.16	0.03	0.03	0.0	0.31	0.12
Operating Income	0.47	0.03	0.43	0.93	0.98	0.82		0.96	0.97	0.84	0.48	0.96	0.41	0.93	0.95	-0.3	-0.03	0.84	0.39	0.62	0.23	-0.21	0.21	-0.26	0.58	0.28
Ebit	0.33	-0.03	0.47	0.9	0.94	0.8	0.96		1.0	0.82	0.52	1.0	0.46	0.99	0.9	-0.26	0.03	0.91	0.34	0.61	0.12	-0.12	0.29	-0.16	0.57	0.25
Ebitda	0.4	-0.02	0.46	0.91	0.95	0.81	0.97	1.0		0.83	0.52	1.0	0.43	0.99	0.92	-0.28	0.0	0.9	0.36	0.62	0.1	-0.17	0.3	-0.21	0.56	0.24
Cost Of Revenue	0.44	0.51	0.79	0.98	0.89	1.0	0.84	0.82	0.83		0.79	0.79	0.13	0.79	0.73	-0.75	0.07	0.52	0.78	0.25	0.16	0.02	0.03	-0.01	0.32	0.12
Total Operating Expenses	0.14	0.64	0.89	0.72	0.59	0.82	0.48	0.52	0.52	0.79		0.48	0.01	0.49	0.4	-0.78	0.39	0.2	0.79	0.07	0.05	0.13	-0.04	0.12	0.11	0.01
Income Before Tax	0.39	-0.08	0.42	0.89	0.95	0.78	0.96	1.0	1.0	0.79	0.48		0.45	0.99	0.92	-0.23	-0.01	0.92	0.31	0.65	0.09	-0.19	0.32	-0.22	0.56	0.24
Total Other Income Expense Net	-0.12	-0.44	-0.04	0.22	0.32	0.13	0.41	0.46	0.43	0.13	0.01	0.45		0.43	0.47	0.23	0.24	0.52	-0.13	0.45	-0.01	-0.23	0.33	-0.26	0.48	0.28
Net Income	0.32	-0.05	0.43	0.87	0.92	0.78	0.93	0.99	0.99	0.79	0.49	0.99	0.43		0.86	-0.23	-0.02	0.93	0.3	0.57	0.1	-0.08	0.28	-0.12	0.56	0.21
Income Tax Expense	0.54	-0.12	0.35	0.84	0.92	0.72	0.95	0.9	0.92	0.73	0.4	0.92	0.47	0.86		-0.21	0.0	0.8	0.31	0.77	0.07	-0.46	0.39	-0.49	0.52	0.29
Selling And Marketing Expenses	-0.36	-0.85	-0.82	-0.61	-0.39	-0.76	-0.3	-0.26	-0.28	-0.75	-0.78	-0.23	0.23	-0.23	-0.21		-0.06	0.14	-0.95	0.29	0.09	-0.13	0.13	-0.15	0.24	0.14
Minority Interest	-0.43	0.2	0.45	0.04	0.0	0.09	-0.03	0.03	0.0	0.07	0.39	-0.01	0.24	-0.02	0.0	-0.06		-0.04	0.1	0.13	0.25	-0.01	-0.21	-0.02	0.08	0.11
Net Income From Continuing Ops	0.21	-0.38	0.13	0.66	0.79	0.5	0.84	0.91	0.9	0.52	0.2	0.92	0.52	0.93	0.8	0.14	-0.04		-0.06	0.7	0.12	-0.15	0.33	-0.19	0.65	0.25
Non Operating Income Net Other	0.34	0.82	0.86	0.65	0.44	0.8	0.39	0.34	0.36	0.78	0.79	0.31	-0.13	0.3	0.31	-0.95	0.1	-0.06		-0.16	0.07	0.15	0.01	0.15	-0.02	0.17
Tax Provision	0.31	-0.52	-0.01	0.4	0.57	0.24	0.62	0.61	0.62	0.25	0.07	0.65	0.45	0.57	0.77	0.29	0.13	0.7	-0.16		0.0	-0.65	0.58	-0.69	0.63	0.38
Interest Income	-0.17	0.25	0.1	0.18	0.18	0.16	0.23	0.12	0.1	0.16	0.05	0.09	-0.01	0.1	0.07	0.09	0.25	0.12	0.07	0.0		0.37	-0.52	0.3	0.48	0.5
Discontinued Operations	-0.63	0.37	0.21	-0.08	-0.19	0.03	-0.21	-0.12	-0.17	0.02	0.13	-0.19	-0.23	-0.08	-0.46	-0.13	-0.01	-0.15	0.15	-0.65	0.37		-0.42	1.0	-0.03	0.07
Net Interest Income	0.24	-0.47	-0.02	0.08	0.14	0.03	0.21	0.29	0.3	0.03	-0.04	0.32	0.33	0.28	0.39	0.13	-0.21	0.33	0.01	0.58	-0.52	-0.42		-0.42	0.29	0.44
Extraordinary Items	-0.62	0.38	0.2	-0.11	-0.23	0.0	-0.26	-0.16	-0.21	-0.01	0.12	-0.22	-0.26	-0.12	-0.49	-0.15	-0.02	-0.19	0.15	-0.69	0.3	1.0	-0.42		-0.11	0.01
Reconciled Depreciation	0.03	-0.26	0.09	0.41	0.51	0.31	0.58	0.57	0.56	0.32	0.11	0.56	0.48	0.56	0.52	0.24	0.08	0.65	-0.02	0.63	0.48	-0.03	0.29	-0.11		0.66
Non Recurring	-0.06	-0.05	0.15	0.13	0.14	0.12	0.28	0.25	0.24	0.12	0.01	0.24	0.28	0.21	0.29	0.14	0.11	0.25	0.17	0.38	0.5	0.07	0.44	0.01	0.66

Click cells to compare fundamentals

Core Laboratories Account Relationship Matchups

Core Laboratories income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Depreciation And Amortization	171.9K	20.9M	18.5M	17.2M	15.8M	19.2M
Interest Expense	14.7M	14.4M	9.2M	11.6M	13.4M	10.1M
Selling General Administrative	48.0M	34.0M	44.2M	38.1M	40.3M	34.6M
Total Revenue	668.2M	487.3M	470.3M	489.7M	509.8M	619.3M
Gross Profit	150.0M	91.6M	83.8M	78.9M	94.0M	171.1M
Other Operating Expenses	566.2M	429.7M	430.6M	448.2M	455.2M	493.9M
Operating Income	96.7M	55.8M	45.3M	41.5M	54.6M	51.9M
Ebit	119.1M	(77.4M)	45.3M	41.5M	54.6M	51.9M
Ebitda	119.3M	(56.5M)	63.8M	58.7M	70.4M	66.9M
Cost Of Revenue	518.2M	395.6M	386.4M	410.8M	415.7M	448.2M
Total Operating Expenses	48.0M	34.0M	44.2M	37.4M	39.4M	45.7M
Income Before Tax	82.0M	(91.2M)	36.1M	30.0M	41.2M	39.1M
Total Other Income Expense Net	(14.7M)	(14.4M)	(9.2M)	(11.6M)	(13.4M)	(12.8M)
Net Income	102.0M	(97.1M)	19.7M	19.5M	36.7M	34.8M
Income Tax Expense	(12.3M)	5.9M	15.9M	10.3M	4.2M	4.0M
Net Income Applicable To Common Shares	102.0M	(97.6M)	19.7M	19.5M	22.4M	21.3M
Minority Interest	134K	140K	(492K)	(205K)	(350K)	(332.5K)
Net Income From Continuing Ops	94.3M	(97.1M)	20.2M	19.7M	37.0M	35.2M
Tax Provision	(12.3M)	5.9M	15.9M	10.3M	4.2M	4.0M
Interest Income	14.7M	14.4M	9.2M	11.6M	10.4M	9.8M
Discontinued Operations	2.1M	(58K)	7.8M	(424K)	(487.6K)	(463.2K)
Net Interest Income	(14.7M)	(14.4M)	(9.2M)	(11.6M)	(13.4M)	(14.1M)
Reconciled Depreciation	22.6M	20.9M	18.5M	17.2M	15.8M	16.3M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ESRT	Empire State Realty
C	Citigroup
C	Citigroup

When determining whether Core Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Core Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Core Laboratories Nv Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Core Laboratories Nv Stock:

How To Invest In Core

Details

Is Core Stock a good investment?

Details

What is Core Laboratories' Net Worth?

Details

Largest Oil & Gas Equipment & Services Companies

View

Largest Energy Companies

View

You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Is Oil & Gas Equipment & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Core Laboratories. If investors know Core will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Core Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.316

Dividend Share

0.04

Earnings Share

0.54

Revenue Per Share

11.158

Quarterly Revenue Growth

0.072

The market value of Core Laboratories is measured differently than its book value, which is the value of Core that is recorded on the company's balance sheet. Investors also form their own opinion of Core Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Core Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Core Laboratories' market value can be influenced by many factors that don't directly affect Core Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Core Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Core Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Core Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Core Historical Income Statement

About Core Income Statement Analysis

Core Laboratories Income Statement Chart

Total Revenue

Gross Profit

Other Operating Expenses

Core Laboratories income statement Correlations

Core Laboratories Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Core Laboratories income statement Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cost Of Revenue	+ 1.0	Other Operating Expenses
Ebitda	+ 1.0	Ebit
Income Before Tax	+ 1.0	Ebit
Income Before Tax	+ 1.0	Ebitda
Extraordinary Items	+ 1.0	Discontinued Operations
Net Income	+ 0.99	Ebit

Non Operating Income Net Other	- 0.95	Selling And Marketing Expenses
Selling And Marketing Expenses	- 0.85	Interest Expense
Selling And Marketing Expenses	- 0.82	Selling General Administrative
Selling And Marketing Expenses	- 0.78	Total Operating Expenses
Selling And Marketing Expenses	- 0.76	Other Operating Expenses
Selling And Marketing Expenses	- 0.75	Cost Of Revenue